Dantrolene: Mechanisms of Neuroprotection and Possible Clinical Applications in the Neurointensive Care Unit

Neurocritical Care

Volumn 10, Issue 1, 2009, Pages 103-115

  Muehlschlegel, Susanne ^a   Sims, John R ^b  

^a UMASS MEMORIAL MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Calcium; Dantrolene; Neuroprotection, ischemia, seizure; Ryanodine receptor; Sarco endoplasmic reticulum; Serotonin; Trauma; Vasospasm

Indexed keywords

CALCIUM; CENTRAL MUSCLE RELAXANT; DANTROLENE; RYANODINE RECEPTOR;

BRAIN DISEASE; DRUG EFFECT; HUMAN; INTENSIVE CARE; PHYSIOLOGY; REVIEW;

BRAIN DISEASES; CALCIUM; DANTROLENE; HUMANS; INTENSIVE CARE; MUSCLE RELAXANTS, CENTRAL; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 63249121147     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-008-9133-4     Document Type: Review

References (115)

1. Harrison GG. Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium. Br J Anaesth. 1975;47(1):62–5. doi:10.1093/bja/47.1.62. DOI: 10.1093/bja/47.1.62
2. Lin CM, Neeru S, Doufas AG, et al. Dantrolene reduces the threshold and gain for shivering. Anesth Analg. 2004;98(5):1318–24. doi:10.1213/01.ANE.0000108968.21212.D7. Table of contents. DOI: 10.1213/01.ANE.0000108968.21212.D7
3. Lydiatt JS, Hill GE. Treatment of heat stroke with dantrolene. JAMA. 1981;246(1):41–2. doi:10.1001/jama.246.1.41. DOI: 10.1001/jama.246.1.41
4. Hadad E, Cohen-Sivan Y, Heled Y, Epstein Y. Clinical review: treatment of heat stroke: should dantrolene be considered? Crit Care. 2005;9(1):86–91. doi:10.1186/cc2923. DOI: 10.1186/cc2923
5. Hall AP, Henry JA. Acute toxic effects of ‘Ecstasy’ (MDMA) and related compounds: overview of pathophysiology and clinical management. Br J Anaesth. 2006;96(6):678–85. doi:10.1093/bja/ael078. DOI: 10.1093/bja/ael078
6. Graber MA, Hoehns TB, Perry PJ. Sertraline-phenelzine drug interaction: a serotonin syndrome reaction. Ann Pharmacother. 1994;28(6):732–5.
7. 2+ release from intracellular stores in cultured cerebral cortical neurons. J Neurochem. 1991;56(3):1075–8. doi:10.1111/j.1471-4159.1991.tb02031.x. DOI: 10.1111/j.1471-4159.1991.tb02031.x
8. MacLennan DH, Duff C, Zorzato F, et al. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature. 1990;343(6258):559–61. doi:10.1038/343559a0. DOI: 10.1038/343559a0
9. Marks AR, Tempst P, Hwang KS, et al. Molecular cloning and characterization of the ryanodine receptor/junctional channel complex cDNA from skeletal muscle sarcoplasmic reticulum. Proc Natl Acad Sci USA. 1989;86(22):8683–7. doi:10.1073/pnas.86.22.8683. DOI: 10.1073/pnas.86.22.8683
10. Balshaw DM, Yamaguchi N, Meissner G. Modulation of intracellular calcium-release channels by calmodulin. J Membr Biol. 2002;185(1):1–8. doi:10.1007/s00232-001-0111-4. DOI: 10.1007/s00232-001-0111-4
11. Giannini G, Conti A, Mammarella S, Scrobogna M, Sorrentino V. The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues. J Cell Biol. 1995;128(5):893–904. doi:10.1083/jcb.128.5.893. DOI: 10.1083/jcb.128.5.893
12. 2+ release by direct and specific action at skeletal muscle ryanodine receptors. J Biol Chem. 1997;272(43):26965–71. doi:10.1074/jbc.272.43.26965. DOI: 10.1074/jbc.272.43.26965
13. 2+ release channels. Molecular mechanism and isoform selectivity. J Biol Chem. 2001;276(17):13810–6.
14. 2+ release. Trends Pharmacol Sci. 1995;16(10):356–9. doi:10.1016/S0165-6147(00)89070-7. DOI: 10.1016/S0165-6147(00)89070-7
15. Wei H, Perry DC. Dantrolene is cytoprotective in two models of neuronal cell death. J Neurochem. 1996;67(6):2390–8.
16. Pelletier MR, Wadia JS, Mills LR, Carlen PL. Seizure-induced cell death produced by repeated tetanic stimulation in vitro: possible role of endoplasmic reticulum calcium stores. J Neurophysiol. 1999;81(6):3054–64.
17. Rutecki PA, Sayin U, Yang Y, Hadar E. Determinants of ictal epileptiform patterns in the hippocampal slice. Epilepsia. 2002;43(Suppl 5):179–83. doi:10.1046/j.1528-1157.43.s.5.34.x. DOI: 10.1046/j.1528-1157.43.s.5.34.x
18. Thorell WE, Leibrock LG, Agrawal SK. Role of RyRs and IP3 receptors after traumatic injury to spinal cord white matter. J Neurotrauma. 2002;19(3):335–42. doi:10.1089/089771502753594909. DOI: 10.1089/089771502753594909
19. Dykes MH. Evaluation of a muscle relaxant: dantrolene sodium (Dantrium). JAMA. 1975;231(8):862–4. doi:10.1001/jama.231.8.862. DOI: 10.1001/jama.231.8.862
20. Lietman PS, Haslam RH, Walcher JR. Pharmacology of dantrolene sodium in children. Arch Phys Med Rehabil. 1974;55(8):388–92.
21. Meyler WJ, Mols-Thurkow HW, Wesseling H. Relationship between plasma concentration and effect of dantrolene sodium in man. Eur J Clin Pharmacol. 1979;16(3):203–9. doi:10.1007/BF00562062. DOI: 10.1007/BF00562062
22. Flewellen EH, Nelson TE, Jones WP, Arens JF, Wagner DL. Dantrolene dose response in awake man: implications for management of malignant hyperthermia. Anesthesiology. 1983;59(4):275–80. doi:10.1097/00000542-198310000-00002. DOI: 10.1097/00000542-198310000-00002
23. Ellis KO, Wessels FL. Muscle relaxant properties of the identified metabolites of dantrolene. Naunyn Schmiedebergs Arch Pharmacol. 1978;301(3):237–40. doi:10.1007/BF00507042. DOI: 10.1007/BF00507042
24. Faling LJ, Petusevsky ML, Snider GL. Nitrofurantoin and dantrolene; liver and lung. Ann Intern Med. 1980;93(1):151.
25. Chan CH. Dantrolene sodium and hepatic injury. Neurology. 1990;40(9):1427–32.
26. Durham JA, Gandolfi AJ, Bentley JB. Hepatotoxicological evaluation of dantrolene sodium. Drug Chem Toxicol. 1984;7(1):23–40. doi:10.3109/01480548409014171. DOI: 10.3109/01480548409014171
27. Yamagishi F, Komoda T, Ohnishi K, Itoh S. Protective effect of dantrolene sodium on carbon tetrachloride induced liver injury in the rat. Res Commun Chem Pathol Pharmacol. 1993;82(2):237–40.
28. Sorensen EM, Acosta D. Comparison of dantrolene sodium with erythromycin estolate using primary cultures of rat hepatocytes. Drug Chem Toxicol. 1985;8(4):219–37. doi:10.3109/01480548509038647. DOI: 10.3109/01480548509038647
29. Petusevsky ML, Faling LJ, Rocklin RE, et al. Pleuropericardial reaction to treatment with dantrolene. JAMA. 1979;242(25):2772–4. doi:10.1001/jama.242.25.2772. DOI: 10.1001/jama.242.25.2772
30. Mahoney JM, Bachtel MD. Pleural effusion associated with chronic dantrolene administration. Ann Pharmacother. 1994;28(5):587–9.
31. Felz MW, Haviland-Foley DJ. Eosinophilic pleural effusion due to dantrolene: resolution with steroid therapy. South Med J. 2001;94(5):502–4.
32. Saltzman LS, Kates RA, Corke BC, Norfleet EA, Heath KR. Hyperkalemia and cardiovascular collapse after verapamil and dantrolene administration in swine. Anesth Analg. 1984;63(5):473–8. doi:10.1213/00000539-198405000-00001. DOI: 10.1213/00000539-198405000-00001
33. Freysz M, Timour Q, Bernaud C, Bertrix L, Faucon G. Cardiac implications of amlodipine-dantrolene combinations. Can J Anaesth. 1996;43(1):50–5.
34. Benveniste H, Drejer J, Schousboe A, Diemer NH. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem. 1984;43(5):1369–74. doi:10.1111/j.1471-4159.1984.tb05396.x. DOI: 10.1111/j.1471-4159.1984.tb05396.x
35. Small DL, Buchan AM. Mechanisms of cerebral ischemia: intracellular cascades and therapeutic interventions. J Cardiothorac Vasc Anesth. 1996;10(1):139–46. doi:10.1016/S1053-0770(96)80189-3. DOI: 10.1016/S1053-0770(96)80189-3
36. Kristian T, Siesjo BK. Calcium in ischemic cell death. Stroke. 1998;29(3):705–18.
37. Somlyo AP, Bond M, Somlyo AV. Calcium content of mitochondria and endoplasmic reticulum in liver frozen rapidly in vivo. Nature. 1985;314(6012):622–5. doi:10.1038/314622a0. DOI: 10.1038/314622a0
38. Carafoli E. Intracellular calcium homeostasis. Annu Rev Biochem. 1987;56:395–433. doi:10.1146/annurev.bi.56.070187.002143. DOI: 10.1146/annurev.bi.56.070187.002143
39. Kohno K, Higuchi T, Ohta S, Kohno K, Kumon Y, Sakaki S. Neuroprotective nitric oxide synthase inhibitor reduces intracellular calcium accumulation following transient global ischemia in the gerbil. Neurosci Lett. 1997;224(1):17–20. doi:10.1016/S0304-3940(97)13459-0. DOI: 10.1016/S0304-3940(97)13459-0
40. Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev. 2003;4(7):552–65. DOI: 10.1038/nrm1150
41. Kaufman RJ. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 1999;13(10):1211–33. doi:10.1101/gad.13.10.1211. DOI: 10.1101/gad.13.10.1211
42. Welihinda AA, Tirasophon W, Kaufman RJ. The cellular response to protein misfolding in the endoplasmic reticulum. Gene Expr. 1999;7(4–6):293–300.
43. Syntichaki P, Tavernarakis N. The biochemistry of neuronal necrosis: rogue biology? Nat Rev. 2003;4(8):672–84. DOI: 10.1038/nrn1174
44. Duzenli S, Bakuridze K, Gepdiremen A. The effects of ruthenium red, dantrolene and nimodipine, alone or in combination, in NMDA induced neurotoxicity of cerebellar granular cell culture of rats. Toxicol In Vitro. 2005;19(5):589–94. doi:10.1016/j.tiv.2005.03.007. DOI: 10.1016/j.tiv.2005.03.007
45. 2+ influx. Exp Brain Res. 1989;76(2):281–91. DOI: 10.1007/BF00247888
46. 2+ responses to N-Methyl-D-aspartate and depolarization in cerebellar granule cells. J Neurochem. 1993;61(2):760–3.
47. Massote PD, Pinheiro AC, Fonseca CG, et al. Protective effect of retinal ischemia by blockers of voltage-dependent calcium channels and intracellular calcium stores. Cell Mol Neurobiol. 2008.
48. Frandsen A, Schousboe A. Mobilization of dantrolene-sensitive intracellular calcium pools is involved in the cytotoxicity induced by quisqualate and N-methyl-D-aspartate but not by 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionate and kainate in cultured cerebral cortical neurons. Proc Natl Acad Sci USA. 1992;89(7):2590–4. doi:10.1073/pnas.89.7.2590. DOI: 10.1073/pnas.89.7.2590
49. 2+ prevents neurotoxicity. Brain Res. 1992;598(1–2):196–202. doi:10.1016/0006-8993(92)90183-A. DOI: 10.1016/0006-8993(92)90183-A
50. 2+]i in cultured rat hippocampal neurons following exposure to N-methyl-D-aspartate. J Physiol. 1992;448:655–76.
51. Nakayama R, Yano T, Ushijima K, Abe E, Terasaki H. Effects of dantrolene on extracellular glutamate concentration and neuronal death in the rat hippocampal CA1 region subjected to transient ischemia. Anesthesiology. 2002;96(3):705–10. doi:10.1097/00000542-200203000-00029. DOI: 10.1097/00000542-200203000-00029
52. Eliasson MJ, Sampei K, Mandir AS, et al. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med. 1997;3(10):1089–95. doi:10.1038/nm1097-1089. DOI: 10.1038/nm1097-1089
53. Zhang J, Dawson VL, Dawson TM, Snyder SH. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science. 1994;263(5147):687–9. doi:10.1126/science.8080500. DOI: 10.1126/science.8080500
54. Tasker RC, Sahota SK, Cotter FE, Williams SR. Early postischemic dantrolene-induced amelioration of poly(ADP-ribose) polymerase-related bioenergetic failure in neonatal rat brain slices. J Cereb Blood Flow Metab. 1998;18(12):1346–56. doi:10.1097/00004647-199812000-00009. DOI: 10.1097/00004647-199812000-00009
55. Moubarak RS, Yuste VJ, Artus C, et al. Sequential activation of poly(ADP-Ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis. Mol Cell Biol. 2007;27(13):4844–62. doi:10.1128/MCB.02141-06. DOI: 10.1128/MCB.02141-06
56. Nath R, Raser KJ, Hajimohammadreza I, Wang KK. Thapsigargin induces apoptosis in SH-SY5Y neuroblastoma cells and cerebrocortical cultures. Biochem Mol Biol Int. 1997;43(1):197–205.
57. Guo Q, Sopher BL, Furukawa K, et al. Alzheimer’s presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J Neurosci. 1997;17(11):4212–22.
58. Wei H, Leeds P, Chen RW, et al. Neuronal apoptosis induced by pharmacological concentrations of 3-hydroxykynurenine: characterization and protection by dantrolene and Bcl-2 overexpression. J Neurochem. 2000;75(1):81–90. doi:10.1046/j.1471-4159.2000.0750081.x. DOI: 10.1046/j.1471-4159.2000.0750081.x
59. Kim BC, Kim HT, Mamura M, Ambudkar IS, Choi KS, Kim SJ. Tumor necrosis factor induces apoptosis in hepatoma cells by increasing Ca(2+) release from the endoplasmic reticulum and suppressing Bcl-2 expression. J Biol Chem. 2002;277(35):31381–9. doi:10.1074/jbc.M203465200. DOI: 10.1074/jbc.M203465200
60. Popescu BO, Oprica M, Sajin M, et al. Dantrolene protects neurons against kainic acid induced apoptosis in vitro and in vivo. J Cell Mol Med. 2002;6(4):555–69. doi:10.1111/j.1582-4934.2002.tb00454.x. DOI: 10.1111/j.1582-4934.2002.tb00454.x
61. Gwak M, Park P, Kim K, et al. The effects of dantrolene on hypoxic-ischemic injury in the neonatal rat brain. Anesth Analg. 2008;106(1):227–33. Table of contents.
62. Gupta S. Molecular signaling in death receptor and mitochondrial pathways of apoptosis. Int J Oncol. 2003;22(1):15–20. Review.
63. Bucholz J, Tsai H, Duckles SP. Intracellular calcium release induced by caffeine is buffered by mitochondria in superior cervical ganglion cells. FASEB J. 1996;10:A 142.
64. 2+ and 5-aminolevulinic acid-derived oxyradicals promote injury to isolated mitochondria? Free Radic Biol Med. 1995;19(3):381–90. doi:10.1016/0891-5849(95)00015-P. DOI: 10.1016/0891-5849(95)00015-P
65. Saunders R, Szymczyk KH, Shapiro IM, Adams CS. Matrix regulation of skeletal cell apoptosis III: mechanism of ion pair-induced apoptosis. J Cell Biochem. 2007;100(3):703–15. DOI: 10.1002/jcb.21001
66. Hayashi T, Kagaya A, Motohashi N, Yamawaki S. Possible mechanism of dantrolene stabilization of cultured neuroblastoma cell plasma membranes. J Neurochem. 1994;63(5):1849–54. DOI: 10.1046/j.1471-4159.1994.63051849.x
67. Bronner C, Wiggins C, Monte D, et al. Compound 48/80 is a potent inhibitor of phospholipase C and a dual modulator of phospholipase A2 from human platelet. Biochim Biophys Acta. 1987;920(3):301–5.
68. Li F, Hayashi T, Jin G, et al. The protective effect of dantrolene on ischemic neuronal cell death is associated with reduced expression of endoplasmic reticulum stress markers. Brain Res. 2005;1048(1–2):59–68. doi:10.1016/j.brainres.2005.04.058. DOI: 10.1016/j.brainres.2005.04.058
69. Xu K, Tavernarakis N, Driscoll M. Necrotic cell death in C. elegans requires the function of calreticulin and regulators of Ca(2+) release from the endoplasmic reticulum. Neuron. 2001;31(6):957–71. doi:10.1016/S0896-6273(01)00432-9.
70. Guo Q, Fu W, Sopher BL, et al. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat Med. 1999;5(1):101–6. doi:10.1038/4789. DOI: 10.1038/4789
71. Mattson MP, Zhu H, Yu J, Kindy MS. Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis. J Neurosci. 2000;20(4):1358–64.
72. Zucchi R, Yu G, Ghelardoni S, Ronca F, Ronca-Testoni S. A3 adenosine receptor stimulation modulates sarcoplasmic reticulum Ca(2+) release in rat heart. Cardiovasc Res. 2001;50(1):56–64. doi:10.1016/S0008-6363(00)00318-7. DOI: 10.1016/S0008-6363(00)00318-7
73. Yu G, Zucchi R, Ronca-Testoni S, Ronca G. Protection of ischemic rat heart by dantrolene, an antagonist of the sarcoplasmic reticulum calcium release channel. Basic Res Cardiol. 2000;95(2):137–43. doi:10.1007/s003950050175. DOI: 10.1007/s003950050175
74. Lopez-Neblina F, Toledo-Pereyra LH, Toledo AH, Walsh J. Ryanodine receptor antagonism protects the ischemic liver and modulates TNF-alpha and IL-10. J Surg Res. 2007;140(1):121–8. doi:10.1016/j.jss.2006.12.003. DOI: 10.1016/j.jss.2006.12.003
75. Husain SZ, Prasad P, Grant WM, Kolodecik TR, Nathanson MH, Gorelick FS. The ryanodine receptor mediates early zymogen activation in pancreatitis. Proc Natl Acad Sci USA. 2005;102(40):14386–91. doi:10.1073/pnas.0503215102. DOI: 10.1073/pnas.0503215102
76. Kross J, Fleischer JE, Milde JH, Gronert GA. No dantrolene protection in a dog model of complete cerebral ischaemia. Neurol Res. 1993;15(1):37–40.
77. Martinez-Sanchez M, Striggow F, Schroder UH, Kahlert S, Reymann KG, Reiser G. Na(+) and Ca(2+) homeostasis pathways, cell death and protection after oxygen-glucose-deprivation in organotypic hippocampal slice cultures. Neuroscience. 2004;128(4):729–40. doi:10.1016/j.neuroscience.2004.06.074. DOI: 10.1016/j.neuroscience.2004.06.074
78. Kim JH, Kim SH, Min KTM, Kim MH, Song SK, Lee BH. Comparison of the cerebral protective effects of thiopental, propofol and dantrolene on focal cerebral ischemia induced by temporary middle cerebral artery occlusion in the rat under the monitoring of compressed spectral array. J Korean Neurosurg Soc. 2002;32:239–45.
79. 2+ elevation induced by in vitro ischemia-like condition in hippocampal slices. Brain Res. 1993;601(1–2):103–10. doi:10.1016/0006-8993(93)91700-3. DOI: 10.1016/0006-8993(93)91700-3
80. Wang C, Nguyen HN, Maguire JL, Perry DC. Role of intracellular calcium stores in cell death from oxygen-glucose deprivation in a neuronal cell line. J Cereb Blood Flow Metab. 2002;22(2):206–14. doi:10.1097/00004647-200202000-00008. DOI: 10.1097/00004647-200202000-00008
81. Zhang L, Andou Y, Masuda S, Mitani A, Kataoka K. Dantrolene protects against ischemic, delayed neuronal death in gerbil brain. Neurosci Lett. 1993;158(1):105–8. doi:10.1016/0304-3940(93)90623-S. DOI: 10.1016/0304-3940(93)90623-S
82. Niebauer M, Gruenthal M. Neuroprotective effects of early vs. late administration of dantrolene in experimental status epilepticus. Neuropharmacology. 1999;38(9):1343–8. doi:10.1016/S0028-3908(99)00059-3. DOI: 10.1016/S0028-3908(99)00059-3
83. GepdIremen A, Duzenl IS, Hacimuftuoglu A, Suleyman H, Oztas S. The effects of dantrolene alone or in combination with nimodipine in glutamate-induced neurotoxicity in cerebellar granular cell cultures of rat pups. Pharmacol Res. 2001;43(3):241–4. doi:10.1006/phrs.2000.0770. DOI: 10.1006/phrs.2000.0770
84. Tizzano JP, Griffey KI, Johnson JA, Fix AS, Helton DR, Schoepp DD. Intracerebral 1S, 3R–1-aminocyclopentane-1, 3-dicarboxylic acid (1S, 3R-ACPD) produces limbic seizures that are not blocked by ionotropic glutamate receptor antagonists. Neurosci Lett. 1993;162(1–2):12–6. doi:10.1016/0304-3940(93)90548-Y. DOI: 10.1016/0304-3940(93)90548-Y
85. Borowicz KK, Gasior M, Kleinrok Z, Czuczwar SJ. Influence of isradipine, niguldipine and dantrolene on the anticonvulsive action of conventional antiepileptics in mice. Eur J Pharmacol. 1997;323(1):45–51. doi:10.1016/S0014-2999(97)00020-4. DOI: 10.1016/S0014-2999(97)00020-4
86. Wuis EW, Rijntjes NV, van der Kleijn E. Whole-body autoradiography of 14C-dantrolene in the marmoset monkey. Pharmacol Toxicol. 1989;64(1):156–8. DOI: 10.1111/j.1600-0773.1989.tb00621.x
87. Enokizono J, Kusuhara H, Ose A, Schinkel AH, Sugiyama Y. Quantitative investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) in limiting brain and testis penetration of xenobiotic compounds. Drug Metab Dispos. 2008;36(6):995–1002. doi:10.1124/dmd.107.019257. DOI: 10.1124/dmd.107.019257
88. Bostrom E, Hammarlund-Udenaes M, Simonsson US. Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine. Anesthesiology. 2008;108(3):495–505.
89. Meyler WJ, Bakker H, Kok JJ, Agoston S, Wesseling H. The effect of dantrolene sodium in relation to blood levels in spastic patients after prolonged administration. J Neurol Neurosurg Psychiatry. 1981;44(4):334–9. DOI: 10.1136/jnnp.44.4.334
90. Nisijima K, Ishiguro T. Does dantrolene influence central dopamine and serotonin metabolism in the neuroleptic malignant syndrome? A retrospective study. Biol Psychiatry. 1993;33(1):45–8. doi:10.1016/0006-3223(93)90277-K. DOI: 10.1016/0006-3223(93)90277-K
91. Shuaib A, Lees KR, Lyden P, et al. NXY-059 for the treatment of acute ischemic stroke. N Engl J Med. 2007;357(6):562–71. doi:10.1056/NEJMoa070240. DOI: 10.1056/NEJMoa070240
92. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117(4):e25–146. doi:10.1161/CIRCULATIONAHA.107.187998. DOI: 10.1161/CIRCULATIONAHA.107.187998
93. Nakayama K, Suzuki S, Sugi H. Physiological and ultrastructural studies on the mechanism of stretch-induced contractile activation in rabbit cerebral artery smooth muscle. Jpn J Physiol. 1986;36(4):745–60. doi:10.2170/jjphysiol.36.745. DOI: 10.2170/jjphysiol.36.745
94. Sims JR, Salomone S. Dantrolene inhibits serotonin and endothelin-1 vasoconstriction in the rat basilar artery. Neurocritical care. 2007;6(3):267 A107.
95. Call GK, Fleming MC, Sealfon S, Levine H, Kistler JP, Fisher CM. Reversible cerebral segmental vasoconstriction. Stroke. 1988;19(9):1159–70.
96. Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB. Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med. 2007;146(1):34–44.
97. Dietrich WD. The importance of brain temperature in cerebral injury. J Neurotrauma. 1992;9(Suppl 2):S475–85.
98. Azzimondi G, Bassein L, Nonino F, et al. Fever in acute stroke worsens prognosis. A prospective study. Stroke. 1995;26(11):2040–3.
99. Reith J, Jorgensen HS, Pedersen PM, et al. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet. 1996;347(8999):422–5. doi:10.1016/S0140-6736(96)90008-2. DOI: 10.1016/S0140-6736(96)90008-2
100. Ginsberg MD, Busto R. Combating hyperthermia in acute stroke: a significant clinical concern. Stroke. 1998;29(2):529–34.
101. Fernandez A, Schmidt JM, Claassen J, et al. Fever after subarachnoid hemorrhage. Risk factors and impact on outcome. Neurology. 2007;68:1013–1019. DOI: 10.1212/01.wnl.0000258543.45879.f5
102. Wartenberg KE, Schmidt JM, Claassen J, et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med. 2006;34(3):617–23. Quiz 24.
103. Lopez M, Sessler DI, Walter K, Emerick T, Ozaki M. Rate and gender dependence of the sweating, vasoconstriction, and shivering thresholds in humans. Anesthesiology. 1994;80(4):780–8. doi:10.1097/00000542-199404000-00009. DOI: 10.1097/00000542-199404000-00009
104. Ralley FE, Wynands JE, Ramsay JG, Carli F, MacSullivan R. The effects of shivering on oxygen consumption and carbon dioxide production in patients rewarming from hypothermic cardiopulmonary bypass. Can J Anaesth. 1988;35(4):332–7.
105. Horvath SM, Spurr GB, Hutt BK, Hamilton LH. Metabolic cost of shivering. J Appl Physiol. 1956;8(6):595–602.
106. Modica PA, Tempelhoff R, White PF. Pro- and anticonvulsant effects of anesthetics (Part II). Anesth Analg. 1990;70(4):433–44. doi:10.1213/00000539-199004000-00016. DOI: 10.1213/00000539-199004000-00016
107. Buggy D, Higgins P, Moran C, O’Donovan F, McCarroll M. Clonidine at induction reduces shivering after general anaesthesia. Can J Anaesth. 1997;44(3):263–7.
108. Bicer C, Esmaoglu A, Akin A, Boyaci A. Dexmedetomidine and meperidine prevent postanaesthetic shivering. Eur J Anaesthesiol. 2006;23(2):149–53. doi:10.1017/S0265021505002061. DOI: 10.1017/S0265021505002061
109. Nath A, Padua RA, Geiger JD. HIV-1 coat protein gp120-induced increases in levels of intrasynaptosomal calcium. Brain Res. 1995;678(1–2):200–6. doi:10.1016/0006-8993(95)00185-S. DOI: 10.1016/0006-8993(95)00185-S
110. Berg M, Bruhn T, Frandsen A, Schousboe A, Diemer NH. Kainic acid-induced seizures and brain damage in the rat: role of calcium homeostasis. J Neurosci Res. 1995;40(5):641–6. doi:10.1002/jnr.490400509. DOI: 10.1002/jnr.490400509
111. Nagatomo I, Hashiguchi W, Tominaga M, Akasaki Y, Uchida M, Takigawa M. Effects of MK-801, dantrolene, and FK506 on convulsive seizures and brain nitric oxide production in seizure-susceptible EL mice. Brain Res. 2001;888(2):306–10. doi:10.1016/S0006-8993(00)03101-2. DOI: 10.1016/S0006-8993(00)03101-2
112. 2+ rise induced by oxygen/glucose deprivation in cortical neurons. Stroke. 1998;29(1):196–201. Discussion 2.
113. Phillis JW, Diaz FG, O’Regan MH, Pilitsis JG. Effects of immunosuppressants, calcineurin inhibition, and blockade of endoplasmic reticulum calcium channels on free fatty acid efflux from the ischemic/reperfused rat cerebral cortex. Brain Res. 2002;957(1):12–24. doi:10.1016/S0006-8993(02)03578-3. DOI: 10.1016/S0006-8993(02)03578-3
114. Yano T, Nakayama R, Imaizumi T, Terasaki H, Ushijima K. Dantrolene ameliorates delayed cell death and concomitant DNA fragmentation in the rat hippocampal CA1 neurons subjected to mild ischemia. Resuscitation. 2001;50(1):117–25. doi:10.1016/S0300-9572(00)00369-5. DOI: 10.1016/S0300-9572(00)00369-5
115. Yoon KW, Mitchell HL, Broder LD, Brooker RW, Delisle RK. Trauma-induced neurotoxicity in rat hippocampal neurons. Stroke. 1996;27(1):122–6.